C
오가노이드사이언스
476040KOSDAQ44.0 / 100
Reference Date: 2026-09-08
Financial Score17.5 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 18.1% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Organoid Science is a biotech company developing regenerative therapies and material evaluation solutions based on organoid technology, including the refractory intestinal ulcer treatment ATORM-C and the ODISEI platform. The company is expanding into precision medicine, customized research reagents, and CDMO services, leveraging its advanced technology recognized as a national strategic innovation in 2023.
Number of Employees
89people
Average Salary
53.9M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
1.79Industry Average 1.202.5Point
Higher than industry avg (caution)
ROE
-78.43Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
19.43Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 3.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
0.0 / 4
Detailed News Sentiment
1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50
- Neutral"투구게 피 그만"…'신약개발' 동물의존 줄인다
국제 규제기관들이 투구게 실험 의존도를 줄이는 새로운 방법을 모색하고 있으나, 직접적인 영향은 제한적임.
Detailed Momentum
52-week position1.0Point
Near 52w low (0%, downtrend)
Current 6,770Won52-week high 44,60052-week low 6,520
1-month return0.0Point
1m -18.14% (strong drop)
Volume trend3.0Point
Volume flat
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral주식매수선택권부여에관한신고2026-08-31
- Neutral반기보고서 (2026.06)2026-08-14